NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Rationality?...list of major PIVOT turning NWBO historical events

Most major PIVOT turning NWBO historical events over the last few years has been greeted here with a barrage of NON resolving controversial posts to which not surprisingly NOTHING became of them or still ongoing or in litigation ie:
1)Initial DCVAX L trial REdesign
2)Why buy Sawston, UK when UK mkt in regulatory limbo and Germany requires local mfg!
3)Neil Woodford's last $30 mln $5.50/shr funding
4)ONDRA Affair Nov. 2015
5)June 2016 Russell indices REBALANCING
6)BREXIT impact on UK Approval & Sawston

and NOW:

7)BioPharma's clandestine takeover attempts(via recent spate of offerings) of acquiring NWBO:

Along with Cognate being private and owned by Toucan/LP, the PRIMAL BASIS is contained in NWBO Delaware Articles of Incorp since 1998 which is summarized less than 2 mos ago in 2016 SEC 10K:

Toucan Capital and its affiliates, including Linda Powers and Cognate BioServices, are the principal holders of our shares of common stock, and this concentration of ownership may have a negative effect on the market price of our common stock.

As of December 31, 2016, Toucan Capital and its affiliates (including Cognate BioServices, Toucan Partners and Linda Powers, who also serves as our Chief Executive Officer and Chairperson of the Board of Directors), collectively, beneficially owned a significant percentage of our outstanding common stock on that date. This concentration of ownership could involve conflicts of interest, and may adversely affect the trading price of our common stock because investors may perceive disadvantages in owning stock of companies with controlling stockholders, including controlling stockholders who could have conflicts of interest. Toucan Capital and its affiliates, including Linda Powers and Cognate BioServices, have the ability to exert substantial influence over all matters requiring approval by our stockholders, including the election and removal of directors and any proposed merger, consolidation or sale of all or substantially all of our assets, as well as over our business plans, strategies or operations. This influence could have the effect of delaying, deferring or preventing a change in control, or impeding a merger or consolidation, takeover or other business combination or action that could be favorable to investors[/quote ] https://www.sec.gov/Archives/edgar/data/1072379/000114420417020754/v464066_10k.htm#a_015

Going off the deep end in ALL of the above (there may be more) as indicated in all of the above is all for naught.

Lots of STORMS.

Lost at sea?.....In absentia?:

Evidently missing critical business understanding

GLTA especially NWBO, the patients, and investors.

DIFFERENT STROKES FOR DIFFERENT FOLKS